Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
Risk factors for HIV and multiple drug resistant tuberculosis in civilian and penitentiary sectors in Samara, Russia Source: Eur Respir J 2003; 22: Suppl. 45, 345s Year: 2003
Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008
Study of drug resistance among untreated new cases of tuberculosis in Oran, Algeria Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
A tale of two settings: The role of the Beijing genotype in the rise of multidrug resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Change of the nature of micobacterial population, frequency of primary and acquired drug resistanse of M.tuberculosis in TB patients in the Republic of Dagestan Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia Source: Eur Respir J 2012; 40: 133-142 Year: 2012
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
Drug resistant tuberculosis in Belarus Source: Eur Respir J 2003; 22: Suppl. 45, 519s Year: 2003
Clinical and mutational profile of extensively drug resistant tuberculosis cases in northern India. Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Surveillance of M. tuberculosis drug resistance in Russia Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001
Outcomes of MDR cases in Iasi county, Romania Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Tuberculosis epidemiology and drug resistance in prisons of Lithuania Source: Eur Respir J 2004; 24: Suppl. 48, 193s Year: 2004